Selzentry - soon on store shelves

Forbes announced that Selzentry is approved for HIV.
As you probably know by now, Selzentry (aka maraviroc) is oral medication to fight the HIV - in other words, to treat the virus that causes AIDS.
Ion Monday, U.S. Food and Drug Administration has apparoved Selzentry.

Selzentry blocks viral entry into disease-fighting white blood cells. Futher on, it reduces viral load and increases T-cell counts in people who are already being treated for certain strains of HIV.

Selzentry is the first in a new class of oral HIV medicines in more than 10 years. So-called CCR5 antagonists are designed to stop the virus outside the surface of cells before it enters, rather than fighting the virus inside as do other oral HIV medicines.

Interesting fact is, Selzentry was granted accelerated approval - this means that Selzentry appear to provide a significant therapeutic benefit over existing drugs for serious or life-threatening diseases.

Look for Selzentry on store shelves around mid-September this year.